A Multicenter, Prospective, Phase II Study of Ruxolitinib in Chinese Patients with Polycythemia Vera Resistant/Intolerant to Hydroxyurea and/or Interferon-Α
Latest Information Update: 19 Sep 2024
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Polycythaemia vera
- Focus Therapeutic Use
- 19 Sep 2024 New trial record